New inhaled drug shows promise for lung disease patients
Disease control
Completed
This study tested an inhaled medication called seralutinib in 390 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe and exercise. The goal was to see if the drug helps people walk farther in six minutes and delays the diseas…
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC